Literature DB >> 23772678

(Biphenyl-4-yl)methylammonium chlorides: potent anticonvulsants that modulate Na+ currents.

Hyosung Lee1, Ki Duk Park, Xiao-Fang Yang, Erik T Dustrude, Sarah M Wilson, Rajesh Khanna, Harold Kohn.   

Abstract

We have reported that compounds containing a biaryl linked unit (Ar-X-Ar') modulated Na(+) currents by promoting slow inactivation and fast inactivation processes and by inducing frequency (use)-dependent inhibition of Na(+) currents. These electrophysiological properties have been associated with the mode of action of several antiepileptic drugs. In this study, we demonstrate that the readily accessible (biphenyl-4-yl)methylammonium chlorides (compound class B) exhibited a broad range of anticonvulsant activities in animal models, and in the maximal electroshock seizure test the activity of (3'-trifluoromethoxybiphenyl-4-yl)methylammonium chloride (8) exceeded that of phenobarbital and phenytoin upon oral administration to rats. Electrophysiological studies of 8 using mouse catecholamine A-differentiated cells and rat embryonic cortical neurons confirmed that 8 promoted slow and fast inactivation in both cell types but did not affect the frequency (use)-dependent block of Na(+) currents.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23772678      PMCID: PMC3842382          DOI: 10.1021/jm4007092

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  27 in total

Review 1.  Ligand identification for G-protein-coupled receptors: a lead generation perspective.

Authors:  Konrad H Bleicher; Luke G Green; Rainer E Martin; Mark Rogers-Evans
Journal:  Curr Opin Chem Biol       Date:  2004-06       Impact factor: 8.822

Review 2.  The action potential in mammalian central neurons.

Authors:  Bruce P Bean
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

3.  Discovery of a potent and selective small molecule hGPR91 antagonist.

Authors:  Debnath Bhuniya; Dhananjay Umrani; Bhavesh Dave; Deepak Salunke; Gagan Kukreja; Jayasagar Gundu; Minakshi Naykodi; Nadim S Shaikh; Prasad Shitole; Santosh Kurhade; Siddhartha De; Sreemita Majumdar; Srinivasa B Reddy; Suhas Tambe; Yogesh Shejul; Anita Chugh; Venkata P Palle; Kasim A Mookhtiar; Doris Cully; Joseph Vacca; Prasun K Chakravarty; Ravi P Nargund; Samuel D Wright; Michael P Graziano; Sheo B Singh; Sophie Roy; Tian-Quan Cai
Journal:  Bioorg Med Chem Lett       Date:  2011-04-28       Impact factor: 2.823

4.  Discovery of a potent and selective 5-ht5A receptor antagonist by high-throughput chemistry.

Authors:  David F Corbett; Tom D Heightman; Stephen F Moss; Steven M Bromidge; Sara A Coggon; Mark J Longley; Ana Maria Roa; Jennifer A Williams; David R Thomas
Journal:  Bioorg Med Chem Lett       Date:  2005-09-15       Impact factor: 2.823

5.  Cdk5-mediated phosphorylation of CRMP-2 enhances its interaction with CaV2.2.

Authors:  Joel M Brittain; Yuying Wang; Omotore Eruvwetere; Rajesh Khanna
Journal:  FEBS Lett       Date:  2012-09-26       Impact factor: 4.124

6.  Development and characterization of novel derivatives of the antiepileptic drug lacosamide that exhibit far greater enhancement in slow inactivation of voltage-gated sodium channels.

Authors:  Yuying Wang; Ki Duk Park; Christophe Salome; Sarah M Wilson; James P Stables; Rihe Liu; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2011-02-16       Impact factor: 4.418

Review 7.  Resurgence of sodium channel research.

Authors:  A L Goldin
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

8.  Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives.

Authors:  D Choi; J P Stables; H Kohn
Journal:  J Med Chem       Date:  1996-04-26       Impact factor: 7.446

9.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

10.  Synthesis and anticonvulsant activities of (R)-N-(4'-substituted)benzyl 2-acetamido-3-methoxypropionamides.

Authors:  Christophe Salomé; Elise Salomé-Grosjean; Ki Duk Park; Pierre Morieux; Robert Swendiman; Erica DeMarco; James P Stables; Harold Kohn
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

View more
  3 in total

1.  Chimeric derivatives of functionalized amino acids and α-aminoamides: compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels.

Authors:  Robert Torregrosa; Xiao-Fang Yang; Erik T Dustrude; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  Bioorg Med Chem       Date:  2015-04-11       Impact factor: 3.641

2.  Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.

Authors:  Ki Duk Park; Xiao-Fang Yang; Erik T Dustrude; Yuying Wang; Matthew S Ripsch; Fletcher A White; Rajesh Khanna; Harold Kohn
Journal:  ACS Chem Neurosci       Date:  2014-12-09       Impact factor: 4.418

3.  Substituted N-(biphenyl-4'-yl)methyl (R)-2-acetamido-3-methoxypropionamides: potent anticonvulsants that affect frequency (use) dependence and slow inactivation of sodium channels.

Authors:  Hyosung Lee; Ki Duk Park; Robert Torregrosa; Xiao-Fang Yang; Erik T Dustrude; Yuying Wang; Sarah M Wilson; Cindy Barbosa; Yucheng Xiao; Theodore R Cummins; Rajesh Khanna; Harold Kohn
Journal:  J Med Chem       Date:  2014-07-15       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.